Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113248422A details a visible-light catalyzed method for chiral azaarenes, offering green synthesis and high enantioselectivity for pharmaceutical intermediates.
Novel photocatalytic route for dihydronaphthalene derivatives offering mild conditions and high yields for pharmaceutical intermediates.
Patent CN112898202A details a mild visible-light photocatalytic method for synthesizing heterocyclyl cyclopropane compounds, offering significant advantages for pharmaceutical intermediate manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel metal-free visible light catalytic method for 1,2,3,4-tetrahydronaphthalene intermediates. Offers high atom utilization and mild conditions for pharma manufacturing.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN114874139A details a green visible-light method for synthesizing dihydroisoquinoline intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN108299296A details a visible-light induced synthesis of phenanthridine derivatives using organic photocatalysts, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN111072605B details a visible-light catalyzed method for fluoroalkyl-substituted benzofurans. Offers mild conditions and high yields for pharma intermediates.
Patent CN110540516B details a mild visible-light protocol for dihydronaphthalenes, offering cost-effective routes for pharmaceutical intermediates.
Patent CN110540516B reveals visible-light mediated synthesis of dihydronaphthalenes. High yield, mild conditions, reliable pharmaceutical intermediate supplier.
Patent CN111892545A reveals a green photocatalytic route for quinoxalinones. Achieve high yields without transition metals, ensuring cost reduction in API manufacturing and reliable supply.
Patent CN112898202B discloses a mild photocatalytic route to heterocyclic cyclopropanes. This technology offers cost reduction in pharmaceutical intermediate manufacturing through scalable, visible-light catalysis.
Patent CN117088826B enables visible light synthesis of oxazoles. Offers green chemistry solutions for reliable pharmaceutical intermediates supplier partners seeking cost reduction.
Novel visible light photocatalysis method for C2-difluoroalkylbenzimidazole derivatives offers mild conditions and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN105669522B reveals metal-free visible light synthesis for high-purity indolinones offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel visible-light catalyzed method for 3-alkyl quinoxalin-2(1H)-ones. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Novel visible-light driven Ru-catalyst enables room-temp alkyne-aldehyde addition. Reduces energy costs and simplifies supply chain for API synthesis.
Patent CN117304094A reveals visible-light method for high-purity 3-trifluoromethylpyridine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN114573512B enables mild visible light synthesis. Reduces toxicity and cost for pharmaceutical intermediates manufacturing supply chain.